Kongressthemen Advance the Targeting of Non-Coding RNAs by Enhancing Target Specificity, Optimizing Formulation & Improving Efficacy for the Accelerated Translation of Safe & Effective Non-Coding RNA Therapeutics
As the RNA revolution continues off the back of the COVID-19 pandemic, large pharma and investors turn their attention to emerging non-coding RNA therapies beyond just mRNA.
